Orthostatic Hypotension Market Size

Market Size in USD Bn

CAGR7.4%

Study Period	2025-2032
Base Year of Estimation	2024
CAGR	7.4%
Market Concentration	High
Major Players	Lundbeck A/S, Theravance Biopharma, Brain Neurotherapy Bio, Inc., Ionis Pharmaceuticals, Inc., Alterity Therapeutics and Among Others

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Orthostatic Hypotension Market Analysis

The orthostatic hypotension market is estimated to be valued at USD 2.07 Bn in 2025 and is expected to reach USD 3.41 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032. The orthostatic hypotension market is witnessing positive growth owing to factors such as increasing incidences of Parkinson's disease, diabetes and hypertension. These conditions make high risk population prone to orthostatic hypotension.